EichorEICHOR
Condition: Respiratory Inflammation Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Respiratory Inflammation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Studies of Phenotypic and Functional Characteristics of Circulating Neutrophil Subpopulations in Patients With Lung Canc
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06244355PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 In
Phase 1 · 1 location(s) · National Institute of Mental Health (NIMH) · NCT06920628Dynamic Airway Resistance & ML: Guide Sputum Suction in Ventilated Patients
NA · 3 location(s) · Affiliated Hospital of Nantong University · NCT07375667Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas
NA · 5 location(s) · Vanderbilt University Medical Center · NCT06427538Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca
Phase N/A · 51 location(s) · Duke University · NCT04278404Corticosteroids in Hyperinflammatory Phenotype of Critical Illness
Phase 2 · 1 location(s) · Bin Du · NCT07511582Early Severe Illness TrAnslational BioLogy InformaticS in Humans
Phase N/A · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT05591924Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
Phase N/A · 6 location(s) · Alexander Horsley · NCT07484607Post-acute COVID-19 Sequelae in Denmark
Phase N/A · 1 location(s) · Hvidovre University Hospital · NCT06191302Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS
Phase 2 · 1 location(s) · Shanghai Yidian Pharmaceutical Technology Development Co., L · NCT07413094Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · 15 location(s) · GlaxoSmithKline · NCT06959095Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT04971564Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07356583PET Imaging CCR2 in Lung Inflammation
EARLY_Phase 1 · 1 location(s) · Washington University School of Medicine · NCT03492762IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condi
NA · 1 location(s) · Max-Planck-Institute of Psychiatry · NCT07197138Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Phase N/A · 1 location(s) · University of Ulm · NCT03044223eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO
Phase 3 · 121 location(s) · GlaxoSmithKline · NCT07177339A Study Measuring Markers of Airway Inflammation in Breath Samples From People With Respiratory Diseases and Healthy Vol
Phase N/A · 1 location(s) · Portsmouth Hospitals NHS Trust · NCT07426718Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT04026360A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for
Phase N/A · 1 location(s) · Ain Shams University · NCT07089524UNC Pleural Fluid Registry
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05620329The Effects of Endotracheal Suctioning on Pain and Serum Markers
NA · 1 location(s) · Loma Linda University · NCT06692400Identification of Biomarkers of Obstructive Sleep Apnea.
NA · 1 location(s) · Medical University of Bialystok · NCT07723144Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases a
Phase N/A · 10 location(s) · Pneumonia Research Network on Genetic Resistance and Suscept · NCT05688774Immune Status and Disease Control of Inflammatory Airway Diseases
Phase N/A · 1 location(s) · First Affiliated Hospital of Ningbo University · NCT07493629Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
Phase 2 · 3 location(s) · Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahw · NCT05270525NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot
Phase N/A · 1 location(s) · St. Olavs Hospital · NCT06646250Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With
NA · 1 location(s) · Medical University of Vienna · NCT05009758Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
Phase 1 · 2 location(s) · Lebanese University · NCT06307249A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chro
Phase 4 · 68 location(s) · Sanofi · NCT07053423
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.